Literature DB >> 17985252

Neurodegenerative diseases: neurotoxins as sufficient etiologic agents?

Christopher A Shaw1, Günter U Höglinger.   

Abstract

A dominant paradigm in neurological disease research is that the primary etiological factors for diseases such as Alzheimer's (AD), Parkinson's (PD), and amyotrophic lateral sclerosis (ALS) are genetic. Opposed to this perspective are the clear observations from epidemiology that purely genetic casual factors account for a relatively small fraction of all cases. Many who support a genetic etiology for neurological disease take the view that while the percentages may be relatively small, these numbers will rise in the future with the inevitable discoveries of additional genetic mutations. The follow up argument is that even if the last is not true, the events triggered by the aberrant genes identified so far will be shown to impact the same neuronal cell death pathways as those activated by environmental factors that trigger most sporadic disease cases. In this article we present a countervailing view that environmental neurotoxins may be the sole sufficient factor in at least three neurological disease clusters. For each, neurotoxins have been isolated and characterized that, at least in animal models, faithfully reproduce each disorder without the need for genetic co-factors. Based on these data, we will propose a set of principles that would enable any potential toxin to be evaluated as an etiological factor in a given neurodegenerative disease. Finally, we will attempt to put environmental toxins into the context of possible genetically-determined susceptibility.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17985252      PMCID: PMC2814816          DOI: 10.1007/s12017-007-8016-8

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  77 in total

1.  Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Caribbean Parkinsonism Study Group.

Authors:  D Caparros-Lefebvre; A Elbaz
Journal:  Lancet       Date:  1999-07-24       Impact factor: 79.321

2.  Parkinsonism-dementia complex, an endemic disease on the island of Guam. I. Clinical features.

Authors:  A HIRANO; L T KURLAND; R S KROOTH; S LESSELL
Journal:  Brain       Date:  1961-12       Impact factor: 13.501

3.  Epidemiologic investigations of amyotrophic lateral sclerosis. I. Preliminary report on geographic distribution, with special reference to the Mariana Islands, including clinical and pathologic observations.

Authors:  L T KURLAND; D W MULDER
Journal:  Neurology       Date:  1954-05       Impact factor: 9.910

4.  Parkinsonism-dementia complex, en endemic disease on the island of Guam. Clinical, pathological, genetic and epidemiological features.

Authors:  L T KURLAND; A HIRANO; N MALAMUD; S LESSELL
Journal:  Trans Am Neurol Assoc       Date:  1961

5.  Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein.

Authors:  Francesco Fornai; Oliver M Schlüter; Paola Lenzi; Marco Gesi; Riccardo Ruffoli; Michela Ferrucci; Gloria Lazzeri; Carla L Busceti; Fabrizio Pontarelli; Giuseppe Battaglia; Antonio Pellegrini; Ferdinando Nicoletti; Stefano Ruggieri; Antonio Paparelli; Thomas C Südhof
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-16       Impact factor: 11.205

Review 6.  Inhibitors of NADH-ubiquinone reductase: an overview.

Authors:  M Degli Esposti
Journal:  Biochim Biophys Acta       Date:  1998-05-06

7.  Examining the interaction of apo E and neurotoxicity on a murine model of ALS-PDC.

Authors:  J M B Wilson; M S Petrik; M H Moghadasian; C A Shaw
Journal:  Can J Physiol Pharmacol       Date:  2005-02       Impact factor: 2.273

8.  Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter.

Authors:  E Bezard; C E Gross; M C Fournier; S Dovero; B Bloch; M Jaber
Journal:  Exp Neurol       Date:  1999-02       Impact factor: 5.330

9.  Similarities and differences between MPTP-induced parkinsonsim and Parkinson's disease. Neuropathologic considerations.

Authors:  L S Forno; L E DeLanney; I Irwin; J W Langston
Journal:  Adv Neurol       Date:  1993

10.  Uptake and accumulation of 1-methyl-4-phenylpyridinium by rat liver mitochondria measured using an ion-selective electrode.

Authors:  G P Davey; K F Tipton; M P Murphy
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

View more
  17 in total

1.  Natural toxins implicated in the development of Parkinson's disease.

Authors:  Mohamed Salama; Oscar Arias-Carrión
Journal:  Ther Adv Neurol Disord       Date:  2011-11       Impact factor: 6.570

Review 2.  Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer's Disease (sAD)-Like Pathology.

Authors:  Pradip K Kamat; Anuradha Kalani; Shivika Rai; Santosh Kumar Tota; Ashok Kumar; Abdullah S Ahmad
Journal:  Mol Neurobiol       Date:  2015-08-23       Impact factor: 5.590

3.  Signaling pathways involved in 1-octen-3-ol-mediated neurotoxicity in Drosophila melanogaster: implication in Parkinson’s disease.

Authors:  Arati A Inamdar; Prakash Masurekar; Muhammad Hossain; Jason R Richardson; Joan W Bennett
Journal:  Neurotox Res       Date:  2014-02       Impact factor: 3.911

Review 4.  Altered microtubule dynamics in neurodegenerative disease: Therapeutic potential of microtubule-stabilizing drugs.

Authors:  Kurt R Brunden; Virginia M-Y Lee; Amos B Smith; John Q Trojanowski; Carlo Ballatore
Journal:  Neurobiol Dis       Date:  2016-12-22       Impact factor: 5.996

Review 5.  Mechanisms and Effects Posed by Neurotoxic Products of Cyanobacteria/Microbial Eukaryotes/Dinoflagellates in Algae Blooms: a Review.

Authors:  Fiona D Mello; Nady Braidy; Helder Marçal; Gilles Guillemin; Seyed Mohammad Nabavi; Brett A Neilan
Journal:  Neurotox Res       Date:  2017-08-23       Impact factor: 3.911

6.  Loss of caspase-2-dependent apoptosis induces autophagy after mitochondrial oxidative stress in primary cultures of young adult cortical neurons.

Authors:  Meenakshi Tiwari; Marisa Lopez-Cruzan; William W Morgan; Brian Herman
Journal:  J Biol Chem       Date:  2011-01-07       Impact factor: 5.157

7.  Fungal-derived semiochemical 1-octen-3-ol disrupts dopamine packaging and causes neurodegeneration.

Authors:  Arati A Inamdar; Muhammad M Hossain; Alison I Bernstein; Gary W Miller; Jason R Richardson; Joan Wennstrom Bennett
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

8.  Branched-chain amino acids induce neurotoxicity in rat cortical cultures.

Authors:  Valentina Contrusciere; Silvia Paradisi; Andrea Matteucci; Fiorella Malchiodi-Albedi
Journal:  Neurotox Res       Date:  2009-09-15       Impact factor: 3.911

Review 9.  Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity.

Authors:  C A Shaw; L Tomljenovic
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

10.  6-Shogaol, an active compound of ginger, protects dopaminergic neurons in Parkinson's disease models via anti-neuroinflammation.

Authors:  Gunhyuk Park; Hyo Geun Kim; Mi Sun Ju; Sang Keun Ha; Yongkon Park; Sun Yeou Kim; Myung Sook Oh
Journal:  Acta Pharmacol Sin       Date:  2013-07-01       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.